Fairvalue-Calculator Fairvalue-Calculator
EN DE

Trilogy Metals Inc (TMQ) Fair Value & Analysis

Basic Materials · US · Market cap $588M

Price$3.56
Fair Value$2.16
Upside-39.3%
Quality0/100
Evidence: Low Range $1.62 – $2.70

Analysis

Trilogy Metals Inc (TMQ) currently trades at $3.56, while our model-based Fair Value estimate is $2.16 — implying the stock looks roughly 39.3% overvalued today. We read business quality at 0/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Trilogy Metals Inc. engages in the exploration and development of mineral properties in the United States. It primarily explores copper, cobalt, lead, zinc, gold, and silver properties. The company principally holds interests in the Upper Kobuk mineral projects that include the Arctic, which contains polymetallic volcanogenic massive sulfide deposits; and Bornite that contains carbonate-hosted copper-cobalt deposits covering an area of approximately 448,217 acres located in the Ambler mining district in Northwest Alaska. The company was formerly known as NovaCopper Inc. and changed its name to Trilogy Metals Inc. in September 2016. Trilogy Metals Inc. was founded in 2004 and is headquartered in Vancouver, Canada.

Open the full interactive analysis →

Similar stocks

BHP Group (BHP) -27% Rio Tinto Group (RTNTF) -40% Grupo México, S.A. (GMBXF) -19% CMOC Group (CMCLY) -20% Vale S.A (VALEN) -96% Anglo American plc (AAUKF) -61%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.